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 Original Article 
Abstract:
Penicillium  chrysogenum PCL501  produced  β-lactam  antibiotics  when  fermented  with  different  agro-wastes:  cassava 
shavings, corncob, sawdust and sugarcane pulp. In vitro antibacterial activity of the culture extracts was tested against four 
clinical bacterial isolates, namely, Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. All 
the culture extracts and standard drug (commercial Benzyl Penicillin) inhibited the growth B. subtilis and E. coli; the potency 
varied with carbon source. Antibacterial activity of extracts from cultures containing cassava shavings and sugarcane pulp 
was comparable with that of the standard drug. The MIC against the susceptible organisms was 0.20mg/ml for the standard 
drug and ranged from 0.40 to 1.50mg/ml  for the culture  extracts.  Neither the culture extracts  nor the standard drug 
inhibited  K.  pneumoniae and  P.  aeruginosa;  the  bacterial  strains  produced β-lactamase  enzymes.  Cassava  shavings  and 
sugarcane pulp are indicated as suitable cheap carbon sources for the production of antibiotics by Penicillium chrysogenum 
PCL501. 
Key Words: Agro-wastes, Penicillium chrysogenum PCL501, Antibiotic production, Phenyl penicillin, Antibacterial activity, β-
lactamase
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Introduction:
Penicillium chrysogenum (formerly,  Penicillium notatum) 
is an important industrial organism due to its ability to 
produce  several  β-lactam  antibiotics,  particularly 
penicillins.1 The chance discovery of Penicillium notatum 
by  Alexander  Fleming  and  the  production  of  the 
revolutionary  drug,  penicillin,  is  perhaps  the  most 
important finding in the history of therapeutic medicine.2 
Two  naturally  occurring  and  commercially  available 
penicillins  are  Benzyl  penicillin  (Penicillin  G) and 
Phenoxy-methyl  penicillin  (Penicillin  V).  The  R-group 
substituent of the penicillin nucleus can be substituted to 
give the molecule different antibacterial properties. The 
antibacterial  effect of β-lactam antibiotics  is  effectively 
nullified by different types of bacteria which produce β-
lactamase,  an  enzyme  that  breaks  the  β-lactam  ring.3 
Clinical  isolates  of  extended-spectrum  β-lactamase 
(ESBL)-producing  bacteria  have  been  reported  in 
different regions of the world.4-6
Efforts  at  improving  penicillin  yields  have  centred  on 
growth optimization, development of available strains of 
P. chrysogenum by classical mutagenesis procedures, and 
the search for better strains of the organism.7,8 Although 
these have led to the availability of cheaper and effective 
penicillins,  further reduction  in production cost of  the 
antibiotics could be achieved by the use of low-cost fer-
mentation substrates.  Residual  plant materials  in urban 
refuse can serve as cheap carbon and energy sources for 
fermentation instead of refined sugars  such as glucose 
and  lactose.9,10 This  could  turn  the  recalcitrant  waste 
plant biomass into a valuable resource and reduce the 
pollution problem caused by its accumulation in the en-
vironment.11,12 In Nigeria,  agro-industrial  wastes abound 
in the form of wood-wastes and crop residues such as 
cassava shavings, corncobs and sugarcane pulp.13 
In this  study,  a strain  of  P.  chrysogenum  (PCL501) was 
fermented on four major waste cellulosic materials (cas-
sava  shavings,  corncob,  sawdust  and  sugarcane  pulp) 
produced in Lagos, Nigeria and the culture extracts were 
tested for antibacterial activity against four clinical bac-
terial isolates (Bacillus subtilis, Escherichia coli, Klebsiella  
pneumoniae and  Pseudomonas aeruginosa). The fungus 
thrives  on sawdust  and sugarcane pulp14  and produces 
hydrolytic  enzymes such as cellulases15  xylanases16,17 and 
pectinases (unpublished data) in media containing agro-
wastes.  The present  results  show that  the  strain  of  P.  
chrysogenum (PCL501) produces effective β-lactam anti-
biotics with antibacterial activity comparable to commer-
cial  benzyl  penicillin  (Retarpen,  Sandox,  Austria).  Two 
waste  plant  materials,  cassava  shavings  and  sugarcane 
pulp, are indicated as suitable low-cost substrates for the 
production of antibiotics by the strain of P. chrysogenum.
Materials and Methods: 
Preparations of Agro-waste materials:
Sawdust of Abora wood (Mitragyna ciliata) was collected 
from sawmills at Ikorodu, Lagos, Nigeria. Mature sugar-
cane  (Saccharum  offinarum)  stems,  fresh  maize  (Zea 
mays)  and  cassava  shavings  (Manihot  esculenta)  were 
purchased from a local market in Mushin, Lagos, Nigeria. 
The crushed sugarcane pulp was soaked overnight  and 
washed  repeatedly  in  distilled  water  until  no  trace  of 
simple sugar was detected. Corncob was obtained by re-
moving the maize grains and cut into small sizes. The ma-
terials were separately dried at 80oC to constant weight 
in  the  oven,  and  milled  using  Marlex  Exceller  grinder 
(Mumbai,  India).  Fine  powder  obtained  after  passing 
each through a sieve of 0.5 mm pore size was used as 
substrate in the fermentation media.
Strain of Penicillium chrysogenum PCL501:
The strain of P. chrysogenum (PCL501) used for this study 
was isolated from a wood-waste dump in Lagos, Nigeria 
and characterized as described previously.18 The organ-
ism was maintained on PDA slant at 4oC.
Growth culture and antibiotic production:
The fungus was sub-cultured on PDA plates and incub-
ated at 30oC for 3-5 days to obtain the spores used for 
antibiotics production. Spores were washed into a sterile 
beaker  using  0.1%  Tween 80  in  0.1M potassium phos-
phate buffer at pH 7.0. The spore suspension was stand-
ardized such that 1 in 10 dilutions has an Absorbance of 
0.48 at 530nm. Fifty millilitres (50 ml) of the spore sus-
pension was aseptically introduced into a litre of sterile 
fermentation media containing per litre of distilled wa-
ter:  6.0g  Ammonium  acetate,  0.5g  NaSO3, 0.02g  Zn-
SO4.7H2O,  0.25g  MgSO4.7H2O,  6.0g  KH2PO4,  0.02g 
FeSO4.7H2O, 0.5g Phenylalanine, and 10.0g carbon source 
(glucose, lactose, cassava shavings, corncob, sawdust or 
sugarcane pulp). The pH was adjusted to 6.0. The flasks 
were  incubated  with  intermittent  shaking  for  21  days 
after  which  the  contents  were  sieved  through  cotton 
wool and filtrate centrifuged to remove cells. The pH of 
the  supernatant  was  adjusted  to  2.5  with  chloroform- 
phosphate  buffer  (20:1)  and  assayed  for  Antibacterial 
activity.
Standard Reference Drug:
Benzyl  penicillin  (Retarpen,  Sandox,  Austria)  was  pur-
chased from the University pharmacy at the college of 
Medicine, University of Lagos. Sixteen (16) mg/ml of the 
drug  in  0.1M potassium phosphate  buffer  (pH  7)  was 
used as standard reference drug for the in vitro tests.
Clinical Bacterial Isolates:
Clinical isolates of Bacillus subtilis, Escherichia coli, Kleb-
siella pneumoniae and Pseudomonas aeruginosa used for 
the study were provided by the Department of Medical 
Microbiology and Parasitology, College of Medicine, Uni-
versity of Lagos, Nigeria.
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Antibacterial Sensitivity Testing:
Antibacterial activity of the culture extracts was assayed 
by a modified method of Grau and Halliday.19 Nutrient 
agar plates were seeded with 0.1 ml of an overnight cul-
ture of each clinical isolate (equivalent to 107 – 108  CFU 
ml-1). A sterile cork borer of 8 mm diameter was used to 
cut three uniform wells on the surface of the agar after 
24 hours  of  incubation.  The wells  on each plate  were 
then filled with 0.3 ml of a particular culture extract and 
the effect on the growing "lawns" of each clinical isolate 
was  monitored  at  intervals  of  24  hours.  This  was  re-
peated for each culture extract and the standard drug. 
Zones of clearance round each well means inhibition and 
the diameter; such zones were measured after a marked 
decline in the potency of the antibiotics  to inhibit  the 
growth of the test organisms was noticed.
Determination of MIC
Minimum inhibitory concentration (MIC) was determined 
using the agar dilution guideline of NCCLS as described 
by  Enwuru  et  al.20 The  concentrations  with  inhibitory 
zone diameter of  10.0 mm were chosen for the assay. 
Different dilutions of the extracts were prepared to give 
final concentration in the range of 2.0, 1.0, 0.8, 0.6, 0.4 
and 0.2 mg ml-1 were prepared from a stock solution of 
5mg ml-1. One milliliter (1 ml) of each dilution was mixed 
with 18 ml of Mueller Hinton agar (MHA, Difco, France) 
and poured into Petri-dishes and allowed to set. The agar 
was streaked with an overnight broth culture of the clin-
ical isolates (adjusted to turbidity equivalent to 0.5 Mc-
Farland standards) and incubated at 37°C for 24 hours. 
Controls  containing only the nutrient agar and test or-
ganisms were set up. The plates were then examined for 
the presence or absence of growth. The MIC was defined 
as the lowest concentration of the extract inhibiting the 
visible growth of each organism.
Tests for β-Lactamase activity:
The presence of β-lactamase enzyme in the clinical isol-
ates  was  determined  using  β-lactamase  identification 
sticks (Oxoid, Wesel, Germany) with nitrocefin as the sub-
strate.21 Cells from a 24-hour culture of each isolate were 
collected into a test tube and lysed by sonication.  This 
was  centrifuged  at  4000g  for  15  minutes.  The  super-
natant  diluted  1  in  100 with  nutrient  broth  and  a  β-
lactamase identification stick with nitrocefin as the sub-
strate was inserted into it and allowed to stand for 30 
minutes. Presence of β-lactamase was indicated by a col-
our change from light to deep pink.
Test for β-Lactam antibiotics 
Culture extracts of  P. chrysogenum PCL501 were tested 
to  confirm if  the  antibacterial  activity  was  due to the 
presence of  β-lactam antibiotics.  The supernatant  con-
taining  β-Lactamase  enzyme in  the  previous  assay  was 
used for the test. The supernatant (0.5 ml) was incubated 
with 0.5 ml of the culture extract and allowed to stand 
for 30 minutes at room temperature. The mixture was in-
troduced  into  wells  on  agar  plates  streaked  with  β-
Lactamase-free  E.  coli  strain.  The plates were observed 
for inhibition after 24 hours of incubation.  Absence of 
noticeable zone of inhibition confirms the presence of β-
lactam antibiotics.
Determination of Potency:
The potency of the extracts was determined by a modi-
fication of Carter’s method as described below.21 Three 
plates were used for each sample solution. On each plate 
were two cylinders were filled with the reference dose of 
standard of known concentration, two cylinders with the 
sample solution, and two cylinders with an aliquot of the 
sample solution that  has been treated with the super-
natant containing β-Lactamase enzyme. The plates were 
incubated  overnight  at  30oC and the diameters  of  the 
zones of inhibition were measured. A positive test for the 
presence of an antibiotic residue is indicated by the pro-
duction of zones of inhibition by the sample solution and 
the absence of any detectable zones of inhibition by the 
β-lactamase-treated portion of the sample solution. The 
mean responses for the sample and the reference dose 
of standard were determined and the concentration of 
sample per milliliter of solution was calculated.
Results: 
Plates 1–4 show the in vitro effect of culture extracts of 
Penicillium  chrysogenum PCL501  and  Reference 
antibiotic  (Penicillin  G)  on  the  clinical  isolates  of 
Escherichia  coli,  Bacillus  subtilis,  Pseudomonas 
aeruginosa  and Klebsiella  pneumoniae.  The  reference 
drug  and  all  the  culture  extracts  of  P.  chrysogenum 
inhibited the growth of  E.  coli  and Bacillus  subtilis but 
had no effect on Pseudomonas aeruginosa and Klebsiella  
pneumoniae. The summary of the antibacterial effect of 
the  culture  extracts  and  the  reference  drug  on  the 
clinical  isolates is  presented in Table 1.  All the culture 
extracts  and the  reference drug exhibited antibacterial 
(positive) effects on  E. coli  and Bacillus  subtilis and no 
antibacterial  (negative)  effect  on  Pseudomonas  
aeruginosa and Klebsiella pneumoniae. Table 2 shows the 
average  zone of  inhibition  and potency  of  the  culture 
extracts  of  Penicillium  chrysogenum PCL501  and  the 
reference drug against the clinical isolates of Escherichia  
coli and Bacillus subtilis. The degree of inhibition on the 
growth  of  the  susceptible  clinical  isolates  varied.  The 
diameter of  zone of  inhibition  and potency of  culture 
extracts from sugarcane pulp and cassava shavings were 
very close to that of the reference drug. Table 3 shows 
the  minimum  inhibitory  concentrations  (MICs)  of  the 
culture extracts and the reference drug. The MIC against 
the  susceptible  organisms  was  0.20mg/ml  for  the 
standard drug; it ranged from 0.40 to 1.50mg/ml for the 
culture  extracts.  MIC  was  0.4  -  0.6mg/ml  for  cassava 
shavings and sugarcane pulp, 0.6mg/ml for glucose and 
lactose,  0.8mg/ml  for  corncob  and  1.50mg/ml  for 
sawdust
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.A B C D E
Plate 1 (A–E): In vitro effect of culture extracts of Penicillium chrysogenum PCL501 and the Reference antibiotic on 
the growth of clinical isolate of  Escherichia coli. (Carbon Source: A = cassava shaving, B = sugarcane pulp, C = 
corncob, D = lactose; E = Reference drug)
A B C
Plate 2 (A–C): In vitro effect of some culture extracts of Penicillium chrysogenum PCL501 on the growth of clinical 
isolate of Bacillus subtilis. (Carbon Source: A = cassava shaving; B = sugarcane pulp, C = sawdust).
A B
Plate 3 (A – B): In vitro effect of culture extracts of Penicillium chrysogenum PCL501 and the Reference antibiotic 
on the growth of the clinical isolate of Pseudomonas aeruginosa. (Carbon Source: A = corncob; B = Reference 
drug).
Plate 4: In vitro effect of some culture extracts of Penicillium chrysogenum PCL501 and the 
Reference antibiotic on the clinical isolate of Klebsiella pneumoniae. (Clockwise: Reference 
drug [white], cassava shavings and sugarcane pulp).
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Table 1: Effect of culture extracts of  Penicillium chrysogenum PCL501 and Reference drug on the growth of the 
clinical  isolates  of  Escherichia  coli,  Bacillus  subtilis,  Pseudomonas  aeruginosa and  Klebsiella  pneumoniae (+ = 
inhibition;  - = No visible zone of inhibition)
Antibiotic
Carbon Source of 
culture media
Antibacterial activity on clinical isolates of bacteria
Escherichia coli Bacillus subtilis
Pseudomonas  
aeruginosa
Klebsiella  
pneumoniae
Culture extracts of Penicillium 
chrysogenum PCL501
Cassava shavings + + - - 
Corncob + + - -
Sawdust + + - -
Sugarcane pulp + + - -
Glucose + + - -
Lactose + + - -
Reference antibiotic (Penicillin G) Not applicable + + - -
Table 2: Average diameter of inhibition zone and potency of culture extracts of  Penicillium chrysogenum PCL501 
and Reference drug against clinical isolates of Escherichia coli and Bacillus subtilis.
Source of Antibiotics
Carbon Source of 
culture media
Escherichia coli Bacillus subtilis
Diameter of inhibi-
tion zone (mm)
Potency of an-
tibiotic 
(mg/ml)
Diameter of inhibi-
tion zone (mm)
Potency of anti-
biotic (mg/ml)
Culture extract of Penicillium 
chrysogenum PCL501
Cassava shavings 15.12 ± 0.03 11.76 26.6 ± 0.14 10.43
Corncob 13.63 ± 1.59 11.50 14.75 ± 0.35 5.47
Sawdust 6.25 ± 0.35 3.04 6.75 ± 0.35 3.57
Sugarcane pulp 17.88 ± 0.35 17.95 28.25 ± 1.77 11.41
Glucose 15.00 ± 0.35 8.26 15.75 ± 1.06 5.78
Lactose 14.75 ± 1.41 11.04 17.25 ± 1.06 6.27
Reference antibiotic (Penicillin G) Not applicable 16.93 ± 0.50 16.00 34.46 ± 0.50 16.00
Table 3: Minimum inhibitory concentrations (MICs) of the culture extracts and the reference drug against the 
clinical isolates of Escherichia coli and Bacillus subtilis
Source of Antibiotics
Carbon Source of cul-
ture  media
Minimum Inhibitory Concentration (mg/ ml)
Escherichia coli Bacillus subtilis
Culture extract of Penicillium chrysogenum 
PCL501
Cassava shavings 0.60 0.40
Corncob 0.80 0.80
Sawdust 1.50 1.50
Sugarcane pulp 0.60 0.40
Glucose 0.60 0.60
Lactose 0.60 0.60
Reference antibiotic (Penicillin G) Not applicable 0.20 0.20
Discussion
The culture extracts of P. chrysogenum PCL501 exhibited 
significant antibacterial effects against clinical isolates of 
E. coli and B. subtilis. The results show that the organism 
produces  antibiotics  that  are  effective  against  the  two 
bacterial  isolates.  This  is  consistent  with  the  fact  that 
most  strains  of  Penicillium  chrysogenum produce  β-
lactam antibiotics,  mainly  penicillins.1 The fact that  the 
antibacterial effect of some of the extracts is comparable 
with that obtained with commercial benzyl penicillin (Re-
tarpen,  Sandox,  Austria)  indicate  the  prospect  of  P.  
chrysogenum (PCL501) as potential source of commercial 
antibiotics. This is evident in the diameter of clearance 
zone, potency and MICs of the culture extracts. 
It is interesting to note that the organism produced ef-
fective  antibiotics  in  media  containing  refined  sugars 
(glucose  and  lactose)  as  well  as  those  containing  the 
agro-wastes (cassava shavings,  sugarcane pulp,  corncob 
and sawdust) as sole carbon source. Most studies on suit-
able  substrates  for  Penicillium fermentation  had 
centered on the use of refined substrates such as gluc-
ose,  sucrose,  glycerol,  galactose  and  lactose.22 The 
present result indicates that the waste cellulosic materi-
als  are good substrates for antibiotic  production by  P.  
chrysogenum  PCL501.  Several  studies  have  shown  that 
the organism thrives on waste plant materials and utilizes 
the structural carbohydrates for its growth.14,15,23 The or-
ganism is known to produce a variety of hydrolytic en-
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zymes24,  particularly  cellulases15 and  xylanases17,25  which 
hydrolyze  plant  cell  wall  polysaccharides  thereby  en-
abling it to utilize the polymers for its carbon and energy 
needs. 
Culture extracts from media containing two agro-wastes, 
cassava shavings and sugarcane pulp, yielded greater an-
tibacterial effects than culture extracts from media con-
taining equivalent amount of  glucose and lactose.  This 
indicates  that  the  agro-wastes  can  effectively  serve  as 
cheap fermentation substrates for the production of an-
tibiotics by the strain of Penicillium chrysogenum. Nigeria 
ranks among the highest producer of cassava tubers in 
the world and cassava shavings is a common domestic 
and  agro-industrial  waste  in  the  country.  Sugarcane  is 
also  produced  and  consumed in  large  quantity  in  the 
country. Sugarcane pulp (bagasse) comes from the con-
sumption of sugarcane by the local community and as a 
byproduct of the sugar industries. The use of these ma-
terials, which are abundant in rural and urban refuse, in 
antibiotic production will not only lead to a reduction in 
the production cost of penicillin but also a reduction in 
pollution-load.
The Results show that both the standard penicillin G and 
culture extracts are not effective against the clinical isol-
ates of Pseudomonas aeruginosa and Klebsiella pneumo-
nia.  The  two  bacteria  were  found  to  produce  β-
lactamase enzymes which cleave the β-lactam ring and 
thereby nullify the effect of the β-lactam antibiotics. The 
beta-lactam ring is part of the structure of β-lactam anti-
biotics,  principally  the  penicillins,  cephalosporins,  car-
bapenems and monolactams. This implies that P. chryso-
genum PCL501  produces  β-lactam  antibiotics.  Several 
strains of  Pseudomonas aeruginosa have been reported 
to  produce  β-lactamases.3,26,27 Strains  of  E.  coli and  K.  
pneumoniae producing β-lactamase have also been isol-
ated in different hospitals.5,6 This also confirms the pres-
ence of β-lactamase producing bacteria amongst clinical 
isolates from Nigerian. Since the resistance of the organ-
isms to antibacterial  drugs is both innate and plasmid-
borne28, there could be a high rate of the transference of 
such properties amongst bacterial strains. This calls for a 
review of the antibacterial regimes engaged in the treat-
ment  of  bacterial  infections.  A  combination  of  β-
lactamase inhibitors  with the β-lactam antibiotics  is re-
commended  to  tackle  the  problem  of  the  resistance 
caused by the presence of β-lactamases from bacterial 
cells.
References:
1. De Hoog GS, Guarro J, Figueras MJ, Gené J. At-
las  of  Clinical  Fungi.  2nd  ed.  Centraalbureau 
voor  Schimmelcultures,  Utrecht,  The Nether-
lands  and  Universitat  Rovira  i  Virgili,  Reus, 
Spain, 2000; p. 1124.
2. Volk TJ. Tom Volk's Fungus of the Month for 
November 2003. TomVolkFungi.net, University 
of Wisconsin-La Crosse.
3. Naas T, Naas T, Phiippon L, Poirel L, Ronco E, 
Nordmann P. An SHV-derived extended-spec-
trum β-lactamase in Pseudomonas aeruginosa. 
Antimicrob Agents Chemother 1999;43:1281-4.
4. Baraniak A, Fiett J, Sulikowska A, Hryniewicz W, 
Gniadkowski M. Countrywide Spread of CTX-
M-3  extended-spectrum  ß-lactamase-produ-
cing microorganisms of the Family  Enterobac-
teriaceae in  Poland.  Antimicrol  Agents  and 
Chemother 2002;46;151-159.
5. De Cueto M, López L, Hernández JR, Morillo C, 
Pascual  A.  In  Vitro  Activity  of  Fosfomycin 
against  Extended-Spectrum-β-Lactamase-  Pro-
ducing Escherichia coli and Klebsiella pneumo-
niae: Comparison of Susceptibility Testing Pro-
cedures.  Antimicrob  Agents  Chemother. 
2006;50(1):368–370. doi: 10.1128/AAC.
6. Hernandez JR, Pascual A, Canton R, Martinez-
Martinez L. Extended-spectrum beta lactamase 
producing Escherichia coli and Klebsiella pneu-
moniae in Spanish hospitals (GEIH-BLEE project 
2002).  Enferm.  Infecc.  Microbiol.  Clin. 
2003;21:77-82.
7. Chuan-Bao., Sun Qiu-Lian, Kong Wen-Si Xu. Ef-
ficient  transformation  of  Penicillium  chryso-
genum  mediated  by  Agrobacterium  tumefa-
ciens  LBA4404  for  cloning  of  Vitreoscilla 
hemoglobin gene. EJB  Electronic J  Biotechnol. 
2002;5(1):0717-3458.
8. Veenhuis M. Penicillin production by  Penicilli-
um chrysogenum: role of the microbody mem-
brane  in  the  penicillin  biosynthetic  pathway. 
EJB Electronic Molecular Biology and Genetics J  
Biotechnol. 2002;5;717-3458.
9. Howard  RLI,  Abotsi  E,  Jansen  Van  Rensburg, 
ELI,  Howard  S.  Lignocellulose  biotechnology: 
issues  of  bioconversion  and enzyme produc-
tion. Review. Afri. J. Biotechnol. 2003;2(12):602-
619.
10. Solomon BO, Amigun B, Betiku E, Ojumu TV, 
Layokun SK. Optimization of cellulase produc-
tion by Aspergillus flavus Linn Isolate NSPR101 
Grown on Bagasse. JNSCHE, 1999;16:61-68
11. Adney  WS,  Rivard  CJ,  Ming  SA,  Himmel  ME. 
Anaerobic Digestion of Lignocellulosic Biomass 
and  Wastes.  Cellulases  and  Related  Enzymes. 
Appl. Biochem. Biotechnol. 1991;30:165-183.
12. Rahman AMTF,  Kyesmu PM,  Tom TU.  Biode-
gradation of wheat and corn offal for poultry 
feed production.  Proceedings  of  the Interna-
tional Conference on Biotechnology: Commer-
cialization  and  Food security.  Abuja,  Nigeria, 
2000. p. 63-71.
13. Abu EA, Onyenekwe PC, Ameh DA, Agbaji AS, 
Ado SA. Cellulase (EC 3.2.1.3) production from 
sorghum bran by Aspergillus niger SL1: An as-
http://ojhas.org 6
OJHAS Vol 8 Issue  1(9)   Onyegeme-Okerenta BM e al.  Antibacterial Activity of Culture Extracts of Penicillium chrysogenum PCL501: Effects of Carbon Sources
sessment of pretreatment methods.  Proceed-
ings  of  the International  Conference on Bio-
technology:  Commercialization  and  Food  se-
curity. Abuja, Nigeria, 2000. p. 153-157.
14. Nwodo-Chinedu S, Okochi VI, Omidiji O, Omo-
waye OO, Adeniji  BR,  Olukoju D, Chidozie  F. 
Potentials of cellulosic wastes in media formu-
lation. Afr. J. Biotechnol. 2007;6(3):243-246.
15. Nwodo-Chinedu S, Okochi VI, Smith HA, Oka-
for  UA,  Onyegeme-Okerenta  BM,  Omidiji  O. 
Effect of carbon sources on cellulase (EC 3. 2. 
1.  4)  production  by  wild-type  Penicillium  
chrysogenum PCL501.  Afri.  J.  Biochem.  Res. 
2007;1(1):6-10.
16. Chinedu  Nwodo  S,  Okafor  UA,  Emezue  TN, 
Okochi VI. Xylanase production of  Aspergillus  
niger and  Penicillium chrysogenum from am-
monia  pretreated cellulosic  waste.  Res.  J.  Mi-
crobiol. 2008;3(4):246-253.
17. Okafor UA, Emezue TN, Okochi VI, Onyegeme-
Okerenta  BM,  Nwodo-Chinedu  S.  Xylanase 
production  by  Penicillium  chrysogenum 
PCL501 fermented on cellulosic wastes.  Afr. J.  
Biochem. Res. 2007;1(4): 48-53.
18. Nwodo-Chinedu  S,  Okochi  VI,  Smith  HA, 
Omidiji  O. Isolation of  cellulolytic  microfungi 
involved  in  wood-waste  decomposition:  Pro-
spect  for  enzymatic  hydrolysis  of  cellulosic 
wastes. Int. J. Biomed Hlth Sci. 2005;1(2):41-51.
19. Grau FH, Halliday WJ. The Effect of Nutrients 
on Formation of Penicillin by Washed Myceli-
um of  Penicillium  chrysogenum.  Department 
of Bacteriology, University of Queensland, Bris-
bane, Australia. 1957;69:207.
20. Enwuru NV, Ogbonnia SO,  Nkemehule F, En-
wuru CA, Tolani O. Evaluation of antibacterial 
activity and acute toxicity of the hydroethan-
olic  extract  of  Stachytarpheta angustifolia  
(Mill) Vahl. Afri. J Biotechnol. 2008;7(11):1740-
1744
21. Carter GG. A review of procedures for the de-
tection of residual penicillins in drugs. National 
Center  for  Antibiotics  Analysis,  Bureau  of 
Drugs, FDA, BY-Lines 1977; 8.
22. Nagy  Z,  Keresztessy  Z,  Szentirmai  A,  Biro  S. 
Carbon source regulation of beta galactosidase 
biosynthesis in Penicillium chrysogenum. J. Ba-
sic Microbiol. 2002;41(6):321-362.
23. Onyegeme-Okerenta  BM,  Nwodo  Chinedu  S, 
Okochi  VI,  Okafor  UA.  Agro-waste:  potential 
substrates for  Penicillium chrysogenum.  Int. J.  
Biol. Chem. Sci. 2009;3(2):203-208.
24. Nuero OM, Reyes F. Enzymes for animal feed-
ing  from  Penicillium  chrysogenum  mycelial 
wastes from penicillin manufacture. Lett. Appl.  
Microbiol. 2002;34:413-416.
25. Chinedu  Nwodo  S,  Okafor  UA,  Emezue  TN, 
Okochi VI. Xylanase production of  Aspergillus  
niger and  Penicillium chrysogenum from am-
monia  pretreated cellulosic  waste.  Res.  J.  Mi-
crobiol. 2008;3(4):246-253.
26. Iyobe S, Kusadokoro H, Takahashi A, Yomoda 
S, Okubo T, Nakamura A, O'Hara K. Detection 
of  a  Variant  Metallo-ß-Lactamase,  IMP-10, 
from Two Unrelated Strains  of  Pseudomonas  
aeruginosa and  an  Alcaligenes  xylosoxidans 
Strain. Antimicrobial  Agents  and  Chemother-
apy 2002;46 (6);2014-2016.
27. Mugnier P, Dubrous P, Casin I, Arlet G, Collatz 
E.  A  TEM-derived  extended-spectrum  β 
lactamase  in  Pseudomonas  aeruginosa.  Anti-
microb Agents Chemother 1996;40;2488-93.
28. Shahid M, Malik A, Sheeba. Multidrug resistant 
Pseudomonas aeruginosa strains harbouring R-
plasmids  and  Amp  C  β-lactamases  isolated 
from hospitalized burn patients in tertiary care 
hospital  of  North  India.  FEMS  Lett 
2003;228:181-6.
http://ojhas.org 7
OJHAS Vol 8 Issue  1(9)   Onyegeme-Okerenta BM e al.  Antibacterial Activity of Culture Extracts of Penicillium chrysogenum PCL501: Effects of Carbon Sources
